Anavex Life Sciences Corp. (AVXL) vs Codexis, Inc. (CDXS)
A side-by-side comparison of Anavex Life Sciences Corp. and Codexis, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVXL
Anavex Life Sciences Corp.
$1.65HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CDXS
Codexis, Inc.
$1.39HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AVXL vs CDXS
growth of $100 · dividends reinvested · last 10yAVXL -56.2% (-7.9%/yr)CDXS -68.6% (-10.9%/yr)AVXL compounded faster over this window
AVXL CDXS
AVXL vs CDXS: by the numbers
- •AVXL is the larger company ($152M vs $150M market cap).
- •Both run net losses; AVXL's is the smaller (0.00% vs -39.55% net margin).
Metrics side by side
Valuation
| Metric | AVXL | CDXS |
|---|---|---|
| P/S ratio | N/A | 1.92 |
| P/B ratio | 1.36 | 4.54 |
Profitability
| Metric | AVXL | CDXS |
|---|---|---|
| Gross margin | 0.00% | 83.71% |
| Operating margin | 0.00% | -54.46% |
| Net margin | 0.00% | -39.55% |
| ROE | -21.38% | -93.22% |
| ROIC | -27.25% | -23.41% |
Growth (annualized)
| Metric | AVXL | CDXS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 0.38% |
| Total return CAGR (5Y) | -37.74% | -44.64% |
Frequently asked
- How have AVXL and CDXS total returns compared?
- Over the past 10 years, AVXL delivered -7.93% and CDXS delivered -11.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.